injectable platelet-rich fibrin
injectable platelet-rich fibrin is a biological therapy with 6 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 2 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
1
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
100.0%
2 of 2 finished
0.0%
0 ended early
1
trials recruiting
6
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Comparison of I-PRF, T-PRF, and 0.8% Hyaluronic Acid Applications in Wound Healing After Gingivectomy.
Injectable Platelet-Rich Fibrin Versus Intradermal Tranexamic Acid for Melasma
Clinical Study of i-PRF Intrauterine Perfusion for Endometrial Regeneration and Repair in Moderate to Severe Intrauterine Adhesions
Evaluation of Repeated Injectable PRF Following SRP in Patients With Periodontitis
Effectiveness of iPRF Injections in Temporomandibular Joints Degeneration Management
Clinical Trials (6)
Comparison of I-PRF, T-PRF, and 0.8% Hyaluronic Acid Applications in Wound Healing After Gingivectomy.
Injectable Platelet-Rich Fibrin Versus Intradermal Tranexamic Acid for Melasma
Clinical Study of i-PRF Intrauterine Perfusion for Endometrial Regeneration and Repair in Moderate to Severe Intrauterine Adhesions
Evaluation of Repeated Injectable PRF Following SRP in Patients With Periodontitis
Effectiveness of iPRF Injections in Temporomandibular Joints Degeneration Management
Comparative Evaluation of the Regenerative Capacity of Two Platelet Concentrates
All 6 trials loaded
Drug Details
- Intervention Type
- BIOLOGICAL
- Total Trials
- 6